Success Metrics

Clinical Success Rate
66.7%

Based on 2 completed trials

Completion Rate
67%(2/3)
Active Trials
0(0%)
Results Posted
100%(2 trials)
Terminated
1(25%)

Phase Distribution

Ph not_applicable
4
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
N/ANon-phased studies
4(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(2)
Terminated(1)
Other(1)

Detailed Status

Completed2
Terminated1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
66.7%
Most Advanced
N/A

Trials by Phase

N/A4 (100.0%)

Trials by Status

terminated125%
unknown125%
completed250%

Recent Activity

0 active trials
Showing 4 of 4
terminatednot_applicable

MOTIVATE: Moving to Improve Outcomes for Older Adults

NCT03914469
completednot_applicable

Improving Outcomes for Older Veterans With Chronic Back Pain and Depression

NCT03896035
unknownnot_applicable

Hypertension Prevention Program, Implementation and Scale up- a Hybrid Effectiveness Implementation Study

NCT04899648
completednot_applicable

Anxiety About Casual Exposure to Food Allergens

NCT03349047

Clinical Trials (4)

Showing 4 of 4 trials
NCT03914469Not Applicable

MOTIVATE: Moving to Improve Outcomes for Older Adults

Terminated
NCT03896035Not Applicable

Improving Outcomes for Older Veterans With Chronic Back Pain and Depression

Completed
NCT04899648Not Applicable

Hypertension Prevention Program, Implementation and Scale up- a Hybrid Effectiveness Implementation Study

Unknown
NCT03349047Not Applicable

Anxiety About Casual Exposure to Food Allergens

Completed

All 4 trials loaded

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
4